BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23781066)

  • 1. An Escherichia coli effector protein promotes host mutation via depletion of DNA mismatch repair proteins.
    Maddocks OD; Scanlon KM; Donnenberg MS
    mBio; 2013 Jun; 4(3):e00152-13. PubMed ID: 23781066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteropathogenic Escherichia coli dynamically regulates EGFR signaling in intestinal epithelial cells.
    Roxas JL; Ryan K; Vedantam G; Viswanathan VK
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G374-80. PubMed ID: 24904077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial Targeting of the Enteropathogenic Escherichia coli Map Triggers Calcium Mobilization, ADAM10-MAP Kinase Signaling, and Host Cell Apoptosis.
    Ramachandran RP; Spiegel C; Keren Y; Danieli T; Melamed-Book N; Pal RR; Zlotkin-Rivkin E; Rosenshine I; Aroeti B
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The enteropathogenic E. coli effector EspF targets and disrupts the nucleolus by a process regulated by mitochondrial dysfunction.
    Dean P; Scott JA; Knox AA; Quitard S; Watkins NJ; Kenny B
    PLoS Pathog; 2010 Jun; 6(6):e1000961. PubMed ID: 20585567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E. coli secreted protein F promotes EPEC invasion of intestinal epithelial cells via an SNX9-dependent mechanism.
    Weflen AW; Alto NM; Viswanathan VK; Hecht G
    Cell Microbiol; 2010 Jul; 12(7):919-29. PubMed ID: 20088948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.
    Berger CN; Crepin VF; Baruch K; Mousnier A; Rosenshine I; Frankel G
    mBio; 2012; 3(5):. PubMed ID: 23033475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EspF effector, a bacterial pathogen's Swiss army knife.
    Holmes A; Mühlen S; Roe AJ; Dean P
    Infect Immun; 2010 Nov; 78(11):4445-53. PubMed ID: 20679436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF.
    Nagai T; Abe A; Sasakawa C
    J Biol Chem; 2005 Jan; 280(4):2998-3011. PubMed ID: 15533930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis.
    Viswanathan VK; Weflen A; Koutsouris A; Roxas JL; Hecht G
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1165-70. PubMed ID: 18356531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EspFu-Mediated Actin Assembly Enhances Enteropathogenic
    Martins FH; Kumar A; Abe CM; Carvalho E; Nishiyama-Jr M; Xing C; Sperandio V; Elias WP
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EPEC effector EspF promotes Crumbs3 endocytosis and disrupts epithelial cell polarity.
    Tapia R; Kralicek SE; Hecht GA
    Cell Microbiol; 2017 Nov; 19(11):. PubMed ID: 28618099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N-terminal domain of EspF induces host cell apoptosis after infection with enterohaemorrhagic Escherichia coli O157:H7.
    Zhao S; Zhou Y; Wang C; Yang Y; Wu X; Wei Y; Zhu L; Zhao W; Zhang Q; Wan C
    PLoS One; 2013; 8(1):e55164. PubMed ID: 23372831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteropathogenic
    Roxas JL; Ramamurthy S; Cocchi K; Rutins I; Harishankar A; Agellon A; Wilbur JS; Sylejmani G; Vedantam G; Viswanathan VK
    Gut Microbes; 2022; 14(1):2143224. PubMed ID: 36476073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen exchanger 3 activity.
    Hodges K; Alto NM; Ramaswamy K; Dudeja PK; Hecht G
    Cell Microbiol; 2008 Aug; 10(8):1735-45. PubMed ID: 18433466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of expression, secretion and translocation of type III effectors during enteropathogenic Escherichia coli infection.
    Serapio-Palacios A; Finlay BB
    Curr Opin Microbiol; 2020 Apr; 54():67-76. PubMed ID: 32058947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of Escherichia coli DNA mismatch repair proteins in colon cancer.
    Khan S
    Crit Rev Oncol Hematol; 2015 Dec; 96(3):475-82. PubMed ID: 26014615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tight junctions and enteropathogenic E. coli.
    Weflen AW; Alto NM; Hecht GA
    Ann N Y Acad Sci; 2009 May; 1165():169-74. PubMed ID: 19538303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EspF Interacts with nucleation-promoting factors to recruit junctional proteins into pedestals for pedestal maturation and disruption of paracellular permeability.
    Peralta-Ramírez J; Hernandez JM; Manning-Cela R; Luna-Muñoz J; Garcia-Tovar C; Nougayréde JP; Oswald E; Navarro-Garcia F
    Infect Immun; 2008 Sep; 76(9):3854-68. PubMed ID: 18559425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topology and function of translocated EspZ.
    Haritan N; Bouman EA; Nandi I; Shtuhin-Rahav R; Zlotkin-Rivkin E; Danieli T; Melamed-Book N; Nir-Keren Y; Aroeti B
    mBio; 2023 Aug; 14(4):e0075223. PubMed ID: 37341483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enteropathogenic E. coli effectors EspF and Map independently disrupt tight junctions through distinct mechanisms involving transcriptional and post-transcriptional regulation.
    Singh AP; Sharma S; Pagarware K; Siraji RA; Ansari I; Mandal A; Walling P; Aijaz S
    Sci Rep; 2018 Feb; 8(1):3719. PubMed ID: 29487356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.